AB
TARA icon

Amalgamated Bank’s Protara Therapeutics TARA Stock Holding History

Amalgamated Bank’s Portfolio TARA Stock Details TARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,108
Closed -$6K – 2687
2025
Q4 		$6K Buy
1,108
+5
+0.5% +$28 ﹤0.01% 2676
2025
Q3 		$5K Hold
1,103
– – ﹤0.01% 2799
2025
Q2 		$3K Buy
+1,103
New +$3.81K ﹤0.01% 2933

Other funds holding TARA

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

Amalgamated Bank's TARA Position: Q1 2026 in Review

Amalgamated Bank sold out of Protara Therapeutics (TARA) in Q1 2026, closing a stake of 1,108 shares — an estimated $6K sold.

Amalgamated Bank first reported a position in TARA in Q2 2025 and held it in 3 quarters. The position peaked at $6K in Q4 2025. 114 funds tracked by Wall St. Rank hold TARA as of Q1 2026.

  • Amalgamated Bank reported no remaining Protara Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 1,108 Protara Therapeutics shares in Q1 2026, an estimated $6K.
  • Amalgamated Bank first reported a position in Protara Therapeutics in Q2 2025 and held it in 3 quarters.
  • Amalgamated Bank's Protara Therapeutics position peaked at $6K in Q4 2025.
  • 114 funds tracked by Wall St. Rank held Protara Therapeutics as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.